GlycoNex Competitors and Similar CompaniesClear all
GlycoNex's competitors and similar companies include CytomX Therapeutics and Oncopeptides.
 GlycoNex GlycoNex (台灣醣聯生技醫藥股) is a company developing cancer drugs utilizing glycosphingolipid antigen and human monoclonal antibody technologies. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | ||
Founding Date | Founding Date 2001 | Founding Date 2008 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations TW HQ | Locations South San Francisco, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees N/A | Employees 15815% increase | Employees 80 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 78 m | Valuation ($) 42.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) NT$37.9m (FY, 2025) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) kr71.1m (FY, 2025) |
Cost of goods | Cost of goods NT$14.3m (FY, 2025) | Cost of goods N/A | Cost of goods kr2.5m (FY, 2025) |
Gross profit | Gross profit NT$36.7m (FY, 2025) | Gross profit N/A | Gross profit kr72m (FY, 2025) |
Net income | Net income (NT$235.2m) (FY, 2025) | Net income ($17.4m) (FY, 2025) | Net income (kr249.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company